Uploaded October 2025 | Updated September 2026, 1 week ago
The Global Burden of Disease (GBD) Study 2023, presented at the World Health Summit 2025 and published in The Lancet, shows global mortality rates are falling but not among youths and young adults.
Noncommunicable diseases (NCDs) now account for nearly two-thirds of the world’s total mortality and morbidity – led by ischemic heart disease, stroke, and diabetes. Researchers also estimate that nearly half of all death and disability could be prevented by modifying some of the leading risk factors, such as reducing high levels of blood sugar and high body mass index (BMI). Based on data from over 16,500 collaborators, the study provides essential insights for policymakers, healthcare leaders, and researchers.
The WHS 2025 session, co-hosted by Institute for Health Metrics and Evaluation (IHME) and The Lancet, featured Ximena Aguilera (Minister of Health, Chile), Jane Halton (Chair, Coalition for Epidemic Preparedness Innovations), Richard Horton (Editor-in-Chief, The Lancet), and Christopher Murray (Director, IHME). They launched the GBD 2023 results and explored how the findings could inform evidence-based action.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
The Global Burden of Disease (GBD) Study 2023, presented at the World Health Summit 2025 and published in The Lancet, shows global mortality rates are falling but not among youths and young adults.
Noncommunicable diseases (NCDs) now account for nearly two-thirds of the world’s total mortality and morbidity – led by ischemic heart disease, stroke, and diabetes. Researchers also estimate that nearly half of all death and disability could be prevented by modifying some of the leading risk factors, such as reducing high levels of blood sugar and high body mass index (BMI). Based on data from over 16,500 collaborators, the study provides essential insights for policymakers, healthcare leaders, and researchers.
The WHS 2025 session, co-hosted by Institute for Health Metrics and Evaluation (IHME) and The Lancet, featured Ximena Aguilera (Minister of Health, Chile), Jane Halton (Chair, Coalition for Epidemic Preparedness Innovations), Richard Horton (Editor-in-Chief, The Lancet), and Christopher Murray (Director, IHME). They launched the GBD 2023 results and explored how the findings could inform evidence-based action.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
